As the pharmaceutical industry pursues multi-geography clinical trials, translation has become a critical step, and a potential roadblock, in the process.

Companies face a variety of challenges before they can bring their products to international markets. Chief among these is making the products, systems, and relevant support and marketing materials, as well as the company itself, ready for a different audience.